Acetyl-Histone H4 (K8) Antibody

What is the specificity of commercially available H4K8ac antibodies, and how can researchers validate this specificity?

Antibodies targeting H4K8ac should specifically recognize histone H4 acetylated at lysine 8 with minimal cross-reactivity to other acetylated lysines. Validation methods include:

• Peptide competition assays: H4 peptides containing acetylated K8 residues should block antibody binding, while peptides with other acetylated lysines should not .

• Western blotting with controls: Compare sodium butyrate-treated (increasing acetylation) versus untreated histone preparations .

• Testing against recombinant proteins: Use proteins with defined modifications to confirm specificity .

• Mutational analysis: Testing against samples with mutations at specific lysine residues .

Several antibodies have undergone rigorous validation demonstrating they do not cross-react with other acetylated lysines in histone H4 .

What are the recommended experimental conditions for using H4K8ac antibodies in chromatin immunoprecipitation (ChIP) experiments?

Based on current protocols:

A typical protocol involves preparing chromatin according to standard cross-linking protocols, performing immunoprecipitation with the recommended antibody concentration, and including appropriate controls to assess specificity and background .

What are the different applications of H4K8ac antibodies in epigenetic research?

H4K8ac antibodies can be employed in multiple techniques with the following recommended dilutions:

These techniques collectively enable comprehensive characterization of H4K8ac distribution and function across different experimental contexts .

How can researchers distinguish between acetylation status of individual lysine residues (K5, K8, K12, K16) on histone H4?

Distinguishing between closely positioned acetylation sites requires specialized approaches:

• Highly specific monoclonal antibodies: Several validated antibodies show no cross-reactivity with other acetylated lysines .

• Mass spectrometry: For absolute confirmation of specific modification sites and their co-occurrence patterns.

• Combined ChIP approaches: Sequential ChIP with different modification-specific antibodies.

• Antibody characterization: Some antibodies have unique features, such as the H4K5ac-specific antibody CMA405 that "reacted with K5ac only when the neighboring K8 was unacetylated," allowing discrimination between different acetylation patterns .

• Surface plasmon resonance (SPR): To measure antibody affinities for their respective targets and validate relative binding efficiencies .

These approaches are critical when studying the sequential nature of histone H4 acetylation and context-dependent modification patterns .

What methods are available for real-time visualization of H4K8 acetylation dynamics in living cells?

Recent technological advances have enabled real-time monitoring of histone acetylation:

• FRET-based indicators: Genetically encoded fluorescent resonance energy transfer sensors have been developed specifically for H4K8 acetylation monitoring .

• Indicator design: These utilize "a FRET probe fused tandemly with the BRDT bromodomain and histone H4" to detect acetylation-dependent interactions .

• Applications: These tools allow researchers to "monitor the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors" .

• Functional validation: Mutational analysis confirmed specificity, as "substitution of arginine for four lysines at the acetylation sites K5, K8, K12, and K16 of histone H4 in the indicator (Histac-4KR) caused a significant decrease in the response to TSA" .

These approaches have revealed previously unknown dynamics, including "the decrease in the level of histone H4 K5/K8 acetylation at metaphase" , providing insights into cell cycle-dependent regulation of histone modifications.

What is the role of H4K8 acetylation in transcriptional regulation compared to other histone H4 acetylation marks?

H4K8 acetylation has distinct genomic distribution and functional properties:

• Genomic location: "H4K8ac is part of a 'backbone' of 17 modifications that occupy most active promoters" but appears "more often in active promoters and transcribed regions than others in the backbone group which were found more at transcriptional start sites" .

• Enzyme interactions: Unlike some other modifications, "H4K8ac binds the SWI/SNF complex" but "CBP/p300 proteins do not appear to read H4K8" .

• Functional implications: This interaction pattern "suggests that H4K8ac is involved in transcriptional elongation, rather than initiation" .

• Sequential modification: "The acetylation of histone H4 is thought to occur initially at K16, and then propagates through K12, K8, and K5, progressing in an N-terminal direction" .

• Hyperacetylation signature: "The simultaneous acetylation of both K5 and K8 in histone H4 is indicative of histone H4 hyperacetylation" .

ChIP-seq studies have shown that "acetylation of both H4K8 and H4K16 were enriched around transcription start sites" , highlighting its role in gene regulatory regions.

How does H4K8 acetylation interact with other histone modifications to establish specific chromatin states?

Histone H4K8 acetylation operates within a complex modification network:

• Sequential modification pattern: Acetylation typically "propagates from K16 to K5" in a directional manner .

• Modification dependency: Studies have demonstrated that "K12 acetylation is required for the efficient K5 acetylation," suggesting hierarchical relationships between modifications .

• Competing modifications: "Genome-wide mapping data show that highly active Brdt-bound gene promoters systematically harbor competing histone acetylation and butyrylation" .

• Verification methods: Surface plasmon resonance measurements have shown "that all four antibodies [for different modifications] have similar ranges of affinity," validating comparative studies of these marks .

These interactions can be studied through:

• ChIP-seq correlation analysis

• Sequential ChIP (Re-ChIP)

• Mass spectrometry

• FRET-based indicators for dynamic monitoring

• Pharmacological inhibition of specific enzymes

What is the functional significance of H4K8 acetylation in different cell types and developmental stages?

Recent research has revealed cell type-specific functions of H4K8 acetylation:

• Oligodendrocyte progenitor regulation: "This study identifies acetylation of the histone H4K8 as a regulator of the proliferative capacity of aOPCs" .

• Developmental differences: Researchers observed "higher intensity of H4K8ac in PDGFRα+ aOPCs compared with nOPCs both in the cortex and in the corpus callosum" .

• Transcriptional impact: "Over 60% of the transcripts with higher levels in aOPCs corresponded to genes with chromatin regions bearing the H4K8ac mark" .

• Functional consequence: Inhibition of enzymes responsible for H4K8ac resulted in "decreased transcripts of cell cycle regulators and functional decrease in cell proliferation in aO4+OPC but not in nO4+OPC," demonstrating cell type-specific responses .

Differential H4K8ac levels may "contribute to the transcriptional and functional differences between these two cell types" , highlighting the importance of studying this modification in specific cellular contexts.

How can researchers integrate H4K8ac ChIP-seq data with other genomic approaches?

Multi-omic integration strategies can provide comprehensive insights:

• Transcriptome correlation: Researchers have successfully "overlapped H4K8ac ChIP-seq data (FDR < 0.01, log2FC [aOPC/nOPC] ≥ 1.5) with RNA-seq data (FDR < 0.01, log2FC [aOPC/nOPC] > 1)" .

• Function prediction: In one study, "over 60% of the transcripts with higher levels in aOPCs corresponded to genes with chromatin regions bearing the H4K8ac mark" .

• Ontology analysis: This approach identified "prominent categories related to the regulation of transcription from RNA polymerase II (19.5%), myelin/lipid metabolic process (16.2%), apoptotic process (11.2%), and protein transport (10.4%)" .

• Genomic feature analysis: "Visualization of genomic occupancy led to highly reproducible patterns of peak enrichment... in genomic regions corresponding to genes involved in metabolic processes, progenitor stage genes, and myelin proteins" .

Integration with functional validation, such as "pharmacological inhibition of histone acetyltransferases responsible for H4K8ac deposition" , helps establish causative relationships rather than mere correlations.

What are the best practices for storage and handling of H4K8ac antibodies?

Proper handling is critical for maintaining antibody performance:

Note that many of these antibodies contain sodium azide, which is "a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only" .

What controls should be included in experiments using H4K8ac antibodies?

Proper experimental design requires multiple controls:

• Peptide competition: Include acetylated and non-acetylated peptides to verify specificity .

• Negative controls: "No antibody was added to the beads control" or use non-specific IgG .

• Positive controls: Sodium butyrate-treated cells (increases histone acetylation) .

• Antibody concentration optimization: "Optimal dilutions/concentrations should be determined by the end user" .

• ChIP controls: For ChIP experiments, include input DNA controls and non-specific antibody controls .

• Cross-reactivity testing: When analyzing closely related modifications, verify "no cross reactivity with other acetylated Lysines in Histone H4" .

These controls are essential for accurately interpreting experiments involving histone modifications, particularly when studying subtle changes in acetylation patterns.

How does dynamic competition between acetylation and butyrylation at H4K8 affect gene regulation?

Recent studies have revealed:

• Competing modifications: "Genome-wide mapping data show that highly active Brdt-bound gene promoters systematically harbor competing histone acetylation and butyrylation" .

• Validation approaches: To address concerns about antibody affinity differences potentially skewing results, researchers used "surface plasmon resonance (SPR) to measure the affinities of antibodies for their respective targets" and confirmed "all four antibodies have similar ranges of affinity" .

• Verification through ChIP-qPCR: This approach "demonstrated that the four histone marks are significantly detected at selected genomic regions" .

• Biological significance: These experiments confirmed that "H4K5K8 butyrylation occurs at levels that largely exceed background noise" , suggesting functional relevance.

This competition likely represents an additional layer of epigenetic regulation affecting gene expression programs through differential recruitment of reader proteins with specificity for acetylation versus butyrylation.

What is known about the role of H4K8 acetylation in regulating cell proliferation?

Recent research has identified specific roles in proliferation control:

• Cell-type specific regulation: "This study identifies acetylation of the histone H4K8 as a regulator of the proliferative capacity of aOPCs" .

• Proliferation differences: Researchers observed "a lower percentage of EdU incorporation in aO4+OPCs (22.0% ± 2.5%) compared with nO4+OPCs (41.8% ± 0.6%)" .

• Transcriptional impact: "Over 60% of the transcripts with higher levels in aOPCs corresponded to genes with chromatin regions bearing the H4K8ac mark" .

• Pharmacological manipulation: "Pharmacological inhibition of histone acetyltransferases responsible for H4K8ac deposition" using "garcinol, an inhibitor of KAT2B and KAT3B... and NU-9056, an inhibitor of KAT5, KAT2B, and KAT3B" resulted in "decreased transcripts of cell cycle regulators and functional decrease in cell proliferation in aO4+OPC but not in nO4+OPC" .

These findings highlight the critical role of H4K8 acetylation in regulating proliferation in a cell type-specific manner, with potential implications for understanding cellular differentiation and disease states.

What are common pitfalls in H4K8ac ChIP experiments and how can they be addressed?

Researchers should be aware of several technical challenges:

• Antibody specificity: Ensure antibodies do not cross-react with other acetylated lysines by performing peptide competition assays and using highly specific antibodies .

• Chromatin preparation: Use optimized fixation conditions (typically "formaldehyde for 10 min" ) as over-fixation can mask epitopes.

• Signal-to-noise ratio: Include appropriate controls such as "no antibody was added to the beads control" to assess background.

• Antibody amount optimization: Use recommended amounts (typically "5 μg antibody per 5 μg - 10 μg of Chromatin" ) but optimize for specific experimental conditions.

• Sequential modification effects: Be aware that "K12 acetylation is required for the efficient K5 acetylation" , which may affect interpretation of results.

For ChIP-seq specifically, consider the recommendation for antibody dilution of "1/20 - 1/50" and validate findings with ChIP-qPCR at selected genomic regions .

How can researchers accurately quantify changes in H4K8 acetylation levels?

Multiple quantification approaches can be employed:

• Western blot: Use appropriate loading controls and quantify band intensity across multiple experiments .

• ChIP-qPCR: For site-specific quantification, as demonstrated when researchers "demonstrated that the four histone marks are significantly detected at selected genomic regions" .

• ChIP-seq with spike-in normalization: For genome-wide quantitative comparisons between conditions.

• Immunofluorescence quantification: As performed when researchers measured "the H4K8ac nuclear fluorescent intensity... to assess the effectiveness of the pharmacological inhibitor treatment" .

• FRET-based real-time monitoring: For dynamic measurements in living cells, as described when researchers were able to "monitor the dynamic fluctuation of histone H4 acetylation levels during mitosis" .